These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10484533)

  • 21. [Lipoprotein(a). Its importance as an additional atherosclerosis marker].
    Campos E
    Acta Med Port; 1997 Jan; 10(1):87-93. PubMed ID: 9245184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis.
    Horejsí B; Ceska R
    Physiol Res; 2000; 49 Suppl 1():S63-9. PubMed ID: 10984073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein(a), atherosclerosis, and apolipoprotein(a) gene polymorphism.
    Pati U; Pati N
    Mol Genet Metab; 2000; 71(1-2):87-92. PubMed ID: 11001801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein(a) and its role in occlusive vascular disease.
    Tennant M; McGeachie JK
    Ann R Coll Surg Engl; 1993 Jan; 75(1):3-7. PubMed ID: 8422141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis.
    Asanuma Y; Kawai S; Aoshima H; Kaburaki J; Mizushima Y
    Arthritis Rheum; 1999 Mar; 42(3):443-7. PubMed ID: 10088766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein(a): intrigues and insights.
    Hobbs HH; White AL
    Curr Opin Lipidol; 1999 Jun; 10(3):225-36. PubMed ID: 10431659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between leptin and lipids in atherosclerosis.
    Tamer L; Ercan B; Unlü A; Sucu N; Pekdemir H; Eskandari G; Atik U
    Indian Heart J; 2002; 54(6):692-6. PubMed ID: 12674182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein(a): Looking ahead.
    Scanu AM
    Nutr Metab Cardiovasc Dis; 2005 Oct; 15(5):331-3. PubMed ID: 16216717
    [No Abstract]   [Full Text] [Related]  

  • 29. [A simple procedure for the simultaneous determination of apolipoproteins AI and B using rocket immunoelectrophoresis].
    Oswald B; Winkler L; Schlag B; Dargel R
    Z Med Lab Diagn; 1984; 25(8):411-6. PubMed ID: 6441367
    [No Abstract]   [Full Text] [Related]  

  • 30. [Genetic-epidemiological studies of apolipoprotein(a) polymorphism and its significance in nephrological diseases and type I diabetes mellitus].
    Kronenberg F; Auinger M; Dieplinger H
    Acta Med Austriaca; 1999; 26(5):142-7. PubMed ID: 11512190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lipoprotein(a): risk factor for atherosclerotic vascular disease important to take into account in practice].
    Couderc R; Maachi M
    Ann Biol Clin (Paris); 1999; 57(2):157-67. PubMed ID: 10210742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein (a) and apoliprotein (a) isoform size in thyroid disease: the quest for the golden fleece.
    Duntas LH
    Thyroid; 2003 Apr; 13(4):345-6. PubMed ID: 12812213
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lipoprotein (a) and stroke].
    Ferraro M; Spagnuolo V; Sprovieri M; Mauro GF
    Minerva Med; 2008 Aug; 99(4):399-409. PubMed ID: 18663347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension.
    Sechi LA; Kronenberg F; De Carli S; Falleti E; Zingaro L; Catena C; Utermann G; Bartoli E
    JAMA; 1997 Jun; 277(21):1689-95. PubMed ID: 9169895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lipoprotein (a) - an independent risk factor in atherosclerosis].
    Ezhov MV; Liakishev AA; Pokrovskiĭ SN
    Ter Arkh; 2001; 73(9):76-82. PubMed ID: 11642088
    [No Abstract]   [Full Text] [Related]  

  • 37. [Assays of apolipoproteins A and B as atherogenicity factors in aged patients at hospitals].
    Hofmann D; Sebbane G; Orellana V; Maury S; Kirkacharian M; Tofis V; Nguyen P
    Ann Med Interne (Paris); 1989; 140(1):36-40. PubMed ID: 2660651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lipoprotein(a) as a risk factor for arteriosclerosis].
    Steinmetz A; Utermann G
    Internist (Berl); 1992 Jan; 33(1):24-31. PubMed ID: 1532383
    [No Abstract]   [Full Text] [Related]  

  • 39. Lipoprotein (a) and apolipoprotein (a) in primary antiphospholipid syndrome.
    Bećarević M; Singh S; Majkić-Singh N
    Clin Biochem; 2007 Mar; 40(5-6):317-20. PubMed ID: 17291477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein(A), a unique atherogenic lipoprotein, review on the literature and methodology.
    Pursiainen M
    Oral Surg Oral Diagn; 1993; 4():35-8. PubMed ID: 8935104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.